AAAAAA

   
Results: 1-16 |
Results: 16

Authors: Murawaki, Y Ikuta, Y Koda, M Kawasaki, H
Citation: Y. Murawaki et al., Comparison of clinical laboratory liver tests between asymptomatic HBV andHCV carriers with persistently normal aminotransferase serum levels, HEPATOL RES, 21(1), 2001, pp. 67-75

Authors: Murawaki, Y Ikuta, Y Okamoto, K Koda, M Kawasaki, H
Citation: Y. Murawaki et al., Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C, J GASTRO, 36(6), 2001, pp. 399-406

Authors: Okamoto, K Murawaki, Y Yuasa, I Kawasaki, H
Citation: K. Okamoto et al., Effect of ALDH2 and CYP2E1 gene polymorphisms on drinking behavior and alcoholic liver disease in Japanese male workers, ALC CLIN EX, 25(6), 2001, pp. 19S-23S

Authors: Okada, K Koda, M Murawaki, Y Kawasaki, H
Citation: K. Okada et al., Changes in esophageal variceal pressure after transcatheter arterial embolization for hepatocellular carcinoma, ENDOSCOPY, 33(7), 2001, pp. 595-600

Authors: Koda, M Murawaki, Y Mitsuda, A Oyama, K Okamoto, K Idobe, Y Suou, T Kawasaki, H
Citation: M. Koda et al., Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma - A randomized control study, CANCER, 92(6), 2001, pp. 1516-1524

Authors: Kobayashi, T Murawaki, Y Reddy, PS Abe, M Fujii, N
Citation: T. Kobayashi et al., Molecular imprinting of caffeine and its recognition assay by quartz-crystal microbalance, ANALYT CHIM, 435(1), 2001, pp. 141-149

Authors: Murawaki, Y Kobayashi, M Koda, M Kawasakia, H
Citation: Y. Murawaki et al., Effects of lactulose on intestinal bacterial flora and fecal organic acidsin patients with liver cirrhosis, HEPATOL RES, 17(1), 2000, pp. 56-64

Authors: Koda, M Murawaki, Y Kawasaki, H
Citation: M. Koda et al., Renovascular resistance assessed by color Doppler ultrasonography in patients with chronic liver diseases, J GASTR HEP, 15(12), 2000, pp. 1424-1429

Authors: Koda, M Tanaka, H Murawaki, Y Horie, Y Suou, T Kawasaki, H Ikawa, S
Citation: M. Koda et al., Liver perforation: A serious complication of percutaneous acetic acid injection for hepatocellular carcinoma, HEP-GASTRO, 47(34), 2000, pp. 1110-1112

Authors: Koda, M Murawaki, Y Mitsuda, A Ohyama, K Horie, Y Suou, T Kawasaki, H Ikawa, S
Citation: M. Koda et al., Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma, CANCER, 88(3), 2000, pp. 529-537

Authors: Murawaki, Y Ikuta, Y Idobe, Y Kawasaki, H
Citation: Y. Murawaki et al., Serum matrix metalloproteinase-1 in patients with chronic viral hepatitis, J GASTR HEP, 14(2), 1999, pp. 138-145

Authors: Koda, M Murawaki, Y Idobe, Y Horie, Y Suou, T Kawasaki, H Ikawa, S
Citation: M. Koda et al., Is choledocholithiasis a late complication of nonresectional therapies forhepatocellular carcinoma?, HEP-GASTRO, 46(30), 1999, pp. 3091-3094

Authors: Murawaki, Y Ikuta, Y Okamoto, K Koda, M Kawasaki, H
Citation: Y. Murawaki et al., Serum matrix metalloproteinase-3 (stromelysin-l) concentration in patientswith chronic liver disease, J HEPATOL, 31(3), 1999, pp. 474-481

Authors: Murawaki, Y Yamada, S Ikuta, Y Kawasaki, H
Citation: Y. Murawaki et al., Clinical usefulness of serum matrix metalloproteinase-2 concentration in patients with chronic viral liver disease, J HEPATOL, 30(6), 1999, pp. 1090-1098

Authors: Horie, Y Shigoku, A Tanaka, H Tomie, Y Maeda, N Hoshino, U Koda, M Shiota, G Yamamoto, T Kato, S Murawaki, Y Suou, T Kawasaki, H
Citation: Y. Horie et al., Prognosis for pedunculated hepatocellular carcinoma, ONCOL-BASEL, 57(1), 1999, pp. 23-28

Authors: Murawaki, Y Ikuta, Y Kawasaki, H
Citation: Y. Murawaki et al., Clinical usefulness of serum tissue inhibitor of metalloproteinases (TIMP)-2 assay in patients with chronic liver disease in comparison with serum TIMP-1, CLIN CHIM A, 281(1-2), 1999, pp. 109-120
Risultati: 1-16 |